Kyntra Bio (KYNB) Cost of Revenue (2020 - 2025)
Historic Cost of Revenue for Kyntra Bio (KYNB) over the last 6 years, with Q3 2025 value amounting to $58000.0.
- Kyntra Bio's Cost of Revenue fell 2266.67% to $58000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.5 million, marking a year-over-year decrease of 14605.44%. This contributed to the annual value of $15.6 million for FY2024, which is 29275.62% up from last year.
- Kyntra Bio's Cost of Revenue amounted to $58000.0 in Q3 2025, which was down 2266.67% from $85000.0 recorded in Q2 2025.
- Kyntra Bio's Cost of Revenue's 5-year high stood at $21.1 million during Q1 2024, with a 5-year trough of -$9.5 million in Q4 2023.
- Its 5-year average for Cost of Revenue is $2.8 million, with a median of $3.3 million in 2021.
- In the last 5 years, Kyntra Bio's Cost of Revenue plummeted by 29246.7% in 2023 and then skyrocketed by 50441.13% in 2024.
- Over the past 5 years, Kyntra Bio's Cost of Revenue (Quarter) stood at $3.1 million in 2021, then soared by 57.6% to $4.9 million in 2022, then plummeted by 292.47% to -$9.5 million in 2023, then skyrocketed by 38.33% to -$5.8 million in 2024, then soared by 100.99% to $58000.0 in 2025.
- Its Cost of Revenue stands at $58000.0 for Q3 2025, versus $85000.0 for Q2 2025 and $252000.0 for Q1 2025.